Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Kirn

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Methods in Molecular Medicine|March 11, 2011
A Phase II Trial of Intratumoral Injection with a Selectively Replicating Adenovirus (ONYX-015) in Patients with Recurrent, Refractory Squamous Cell Carcinoma of the Head and NeckD H Kirn
The Journal of Clinical Investigation|April 5, 2000
Replication-selective microbiological agents: fighting cancer with targeted germ warfareD H Kirn
Gene Therapy|June 14, 2000
A tale of two trials: selectively replicating herpesviruses for brain tumorsD H Kirn
The Journal of Clinical Investigation|April 5, 2000
Replication-selective adenoviruses as oncolytic agentsC Heise, D H Kirn
Journal of the National Cancer Institute|June 5, 1996
Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytomaD H Kirn, A Kramer
Molecular Medicine Today|December 1, 1996
Replicating viruses as selective cancer therapeuticsD H Kirn, F McCormick
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and developmentTerry W Hermiston, D H Kirn
Cancer Gene Therapy|December 23, 1999
Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effectsC C Heise, A Williams, J Olesch, et al.
Gene Therapy|August 27, 2010
Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1B Huang, R Sikorski, D H Kirn, et al.
Bulletin of Mathematical Biology|August 11, 2001
Modeling and analysis of a virus that replicates selectively in tumor cellsJ T Wu, H M Byrne, D H Kirn, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Methods in Molecular Medicine|March 11, 2011
A Phase II Trial of Intratumoral Injection with a Selectively Replicating Adenovirus (ONYX-015) in Patients with Recurrent, Refractory Squamous Cell Carcinoma of the Head and NeckD H Kirn
The Journal of Clinical Investigation|April 5, 2000
Replication-selective microbiological agents: fighting cancer with targeted germ warfareD H Kirn
Gene Therapy|June 14, 2000
A tale of two trials: selectively replicating herpesviruses for brain tumorsD H Kirn
The Journal of Clinical Investigation|April 5, 2000
Replication-selective adenoviruses as oncolytic agentsC Heise, D H Kirn
Journal of the National Cancer Institute|June 5, 1996
Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytomaD H Kirn, A Kramer
Molecular Medicine Today|December 1, 1996
Replicating viruses as selective cancer therapeuticsD H Kirn, F McCormick
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and developmentTerry W Hermiston, D H Kirn
Cancer Gene Therapy|December 23, 1999
Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effectsC C Heise, A Williams, J Olesch, et al.
Gene Therapy|August 27, 2010
Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1B Huang, R Sikorski, D H Kirn, et al.
Bulletin of Mathematical Biology|August 11, 2001
Modeling and analysis of a virus that replicates selectively in tumor cellsJ T Wu, H M Byrne, D H Kirn, et al.
Pageof 3